M12-816
ClinicalTrials.gov NCT02925494
Research payments
$626,933
Through program year 2020, $626,933 in research payments was reported against M12-816, across 435 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT02925494
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $29,910 | 9 |
| 2019 | Research | $597,023 | 426 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mark Martens Neptune, NJ Named on 12 payments
- John Partridge Richmond, VA Named on 12 payments
- Jin Hee Kim New York, NY Named on 11 payments
- Gregory Moore Richmond, VA Named on 10 payments
- Ramin Farsad Encinitas, CA Named on 10 payments
- James Simon Washington, DC Named on 9 payments
- Michael Troy San Antonio, TX Named on 9 payments
- Delbert Johns Fort Worth, TX Named on 9 payments
- Andrew Wagner Saginaw, MI Named on 9 payments
- Amber Hatch Winston Salem, NC Named on 8 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.